<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>A New Class Pluripotent Stem Cell Cytotoxic Small <br /> Molecules <br /> Mark Richards1*., Chee Wee Phoon1., Gwendoline Tze Wei Goh2, Eng Khuan Seng1, Xu Ming Guo1, <br /> Cherine Mei Fong Tan1, Woon-Khiong Chan3*, Joel Mun Kin Lee1,4 <br /> 1 School Chemical &amp; Life Sciences, Nanyang Polytechnic, Singapore, 2 Singapore Eye Research Institute, 11 Third Hospital Avenue, Singapore, 3 Department of <br /> Biological Sciences, National University Singapore, Singapore, 4 Food &amp; Human Nutrition Programme (Singapore), School Agriculture, Food Rural Development, <br /> Agriculture Building, Newcastle University, Newcastle Tyne, United Kingdom <br />  <br />  <br />  <br />      <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />      A major concern Pluripotent Stem Cell (PSC)-derived cell replacement therapy risk teratoma formation <span id='am-2' about='protege:FROM' typeof='owl:Thing'>from</span> <br />      contaminating undifferentiated cells. Removal undifferentiated cells differentiated cultures essential step <br />      PSC-based cell therapies safely deployed clinical setting. We report group novel small molecules that <br />      cytotoxic PSCs. Our data indicates molecules specific potent activity allowing rapid <br />      eradication undifferentiated cells. Experiments utilizing mixed PSC primary human neuronal cardiomyocyte <br />      cultures demonstrate 6-fold enrichment specialized cells obtained adversely affecting cell <br />      viability function. Several structural variants synthesized identify key functional groups improve <br />      specificity efficacy. Comparative microarray analysis ensuing RNA knockdown studies revealed involvement the <br />      PERK/ATF4/DDIT3 ER stress pathway. Surprisingly, cell death following ER stress induction associated a <br />      concomitant decrease endogenous ROS levels PSCs. Undifferentiated cells treated molecules preceding <br />      transplantation fail form teratomas SCID mice. Furthermore, molecules remain non-toxic non-teratogenic <span id='am-4' about='protege:TO' typeof='owl:Thing'>to</span> <br />      zebrafish embryos suggesting safely used vivo. <br />  <br />   Citation: Richards M, Phoon CW, Goh GTW, Seng EK, Guo XM, et al. (2014) A New Class Pluripotent Stem Cell Cytotoxic Small Molecules. PLoS ONE 9(3): <br />   e85039. doi:10.1371/journal.pone.0085039 <br />   Editor: Ernst Wolvetang, University Queensland, Australia <br />   Received May 2, 2013; Accepted November 22, 2013; Published March 19, 2014 <br />   Copyright: &#195;&#376; 2014 Richards et al. This open-access article distributed terms Creative Commons Attribution License, permits <br />   unrestricted use, distribution, reproduction medium, provided original author source credited. <br />   Funding: This research supported Singapore Ministry Education Innovation Fund grant MOE IF-2008-1-043. The funders role study <br />   design, data collection analysis, decision publish, preparation manuscript. <br />   Competing Interests: The authors declared competing interests exist. <br />   * E-mail: mark_richards@nyp.gov.sg (MR); dbscwk@nus.edu.sg (WKC) <br />   . These authors contributed equally work. <br />  <br />  <br />  <br /> Introduction                                                                         Pigment Epithelial cells required restore sight patients <br />                                                                                      [13]. <br />     The discovery induced Pluripotent Stem Cells (iPSCs)                          A variety strategies suggested eliminate rogue <br /> Yamanaka co-workers [1] improvements &#226;&#8364;&#732;&#226;&#8364;&#732;xeno-free&#226;&#8364;&#8482;&#226;&#8364;&#8482;                        undifferentiated PSCs residing pool differentiated cells. <br /> and feeder-free PSC culture systems [2] significantly                           These include selective removal undifferentiated PSCs in <br /> advanced prospects PSC-based regenerative medicine                            heterogeneous cell population flow cytometry [14], the <br /> therapies. However, 3 major hurdles regenerative medicine                         development cytotoxic antibodies specifically target <br /> still remain. First, genetic instability PSCs needs                     undifferentiated PSCs [15,16], separation undifferentiated <br /> resolved [3&#226;&#8364;&#8220;6]. Second, scale-up protocols capacity                      PSCs differentiated cells prior transplantation using <br /> culture PSCs generate sufficient numbers cells clinical                    cell sorting methods combination density gradient <br /> application formulated [5,7]. Third, methods                           separation [17,18], deliberate extended differentiation PSC- <br /> consistently completely eliminate teratoma-forming undiffer-                     derivatives allow residual undifferentiated PSCs differentiate <br /> entiated PSCs potentially contaminate clinically important                      undesirable cell type [19], creation transgenic <br /> specialized derivatives need derived [5&#226;&#8364;&#8220;6,8&#226;&#8364;&#8220;12].                               PSC lines suicide genes activated to <br />     The problem tumor formation rogue PSCs                            selectively remove undifferentiated cells transplantation <br /> particularly worrying just 100 hESCs capable forming                       [9,20]. <br /> teratomas [11]. This estimate complete removal                          Many solutions antibody-based. However, while <br /> undifferentiated PSCs certain disease targets billions                  antibodies high specificity relatively difficult and <br /> specialized cells necessary transplantation (eg. diabetes                costly produce. Their routine use enrichment protocols to <br /> heart conditions) particularly daunting. Indeed focus PSC-                   process large numbers cells escalate cost clinical <br /> based cell therapies shifted somewhat clinical trials                   application. Processing cells FACS MACS lengthy <br /> the transplantation smaller numbers cells sufficient                  time consuming ultimately lead cell attrition and <br /> for cure, like case eye disease Macular                          loss cell viability. <br /> Dystrophy tens thousands PSC-derived Retinal <br />  <br />  <br /> PLOS ONE | www.plosone.org                                                       1                               March 2014 | Volume 9 | Issue 3 | e85039 <br />                                                                                                  Pluripotent Stem Cell Cytotoxic Small Molecules <br />  <br />  <br />  <br /> Results                                                                       JC011 tested differentiating BGO1V/hOG cultures <br />                                                                            harbouring hOct4::GFP construct. BGO1V-GFP cultures <br />    To overcome issues associated existing antibody-based          induced differentiate bFGF starvation; differentiating <br /> enrichment paradigms, conducted large-scale screen           cultures treated 4-day intervals 20 mM JC011 and <br /> BGO1V hESC line supported Mouse Embryonic Fibroblast                    cell viability determined Resazurin analysis. A clear trend was <br /> (MEF) feeders identify PSC-specific cytotoxic small molecules.          observable differentiating BGO1V/hOG cultures were <br /> The PSC-MEF co-culture comprises 2 morphologically                  treated JC011. Decreasing GFP levels indicative increasing <br /> distinct cell types, spindle-shaped MEF feeders mixed          PSC differentiation contemporaneous overall <br /> population differentiated cells colony forming hESCs         increase cell viability, confirming specificity JC011 for <br /> high nucleus cytoplasm ratio representing healthy undifferen-           undifferentiated PSC <span id='am-5' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-6' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-14' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-15' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-18' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-23' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-27' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-29' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-33' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-45' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-52' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-56' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-60' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-62' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-63' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-66' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-67' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-73' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-75' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-78' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-80' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span>phenotype</span> (Fig. 2c). <br /> tiated PSCs. These differences morphology unique            Structure-activity relationship studies active hits were <br /> arrangement 2 distinct cell types (MEFs surrounding               carried determine functional groups responsible <br /> distinct hESC colonies) co-culture monolayer helps facilitate       eliciting activity optimise potency these <br /> the visual identification compounds specifically           molecules. A focused library analogues different substit- <br /> cytotoxic hESCs. A &#226;&#8364;&#732;&#226;&#8364;&#732;hollowing-out&#226;&#8364;&#8482;&#226;&#8364;&#8482; effect co-culture           uents aromatic ring, linker varying lengths alkyl side- <br /> would indicative differential cytotoxicity (Fig. 1a&#226;&#8364;&#8220;d).              chains screened (Fig. 3). Our studies crucial to <br />    Briefly, BGO1V-MEF co-cultures treated 10 mM              2 hydroxyl groups present carbon-3 -4 positions on <br /> final concentration compounds 12 hours visual           aromatic ring. As shown data JC005 JC007, <br /> inspection performed stereomicroscope          replacement of hydroxyl groups methoxy <br /> identify small molecules cytotoxic BGO1V            (CH3O-) group led significant drop cytotoxicity towards <br /> would leave MEFs intact.                                               PSCs specialised cells (Fig. 2d). <br />    From screens, 3 structurally related compounds (JC010,                 The activity affected varying <span id='am-3' about='xsp:length' typeof='owl:Thing'>length</span> the <br /> JC011, JC017) in-house synthesized compound library                alkyl chains. JC040, 9-carbon chain, IC50 <br /> that displayed differential cytotoxicity PSCs identi-         value approximately 16 mM (Fig. 2d) slightly more <br /> fied (Fig. 2a). Cell viability analysis performed using            potent JC011. However, extending alkyl chain 10 <br /> Resazurin dye, confirmed Trypan Blue staining (Fig. 1e, f)         carbons (JC049) longer (JC048, JC050) generally decreased <br /> Propidium Iodide DNA content analysis (Fig. 1j, k). Dose response          potency. This attributed increase lipophilicity <br /> relationships 3 active hits generated using         decreases aqueous solubility. Even JC040 <br /> feeder-free cultures 3 PSC lines (BGO1V, H9 iPS-foreskin-          showed higher potency, JC011 selected model <br /> 1) (Fig. 2b). PSC-specific cytotoxic effects 3 compounds         compound screens better solubility profile. <br /> were consistent 3 PSC lines evaluated.           The nature linker alkyl chain the <br /> Overall, JC011 potent, 12 hr treatment            aromatic core investigated. It shown JC011 <br /> with 10 mM JC011 resulted 99% cell death BGO1V               amide linkage potent, compared JC010 <br /> cells feeder-free culture (Fig. 2a). Conversely, cell viability         urea (-NHCONH-) linkage. <br /> figures MRC-5 normal human fibroblasts treated JC011                 To establish treatment hESCs JC011 abolish <br /> at concentrations 100 mM remained high               teratoma formation vivo, treated 16106 BGO1V cells with <br /> 97% cases (Fig. 2b). Average IC50 value 3 PSC lines         20 mM JC011 12 hrs prior injecting treated cells the <br /> tested approximately 20 mM (Fig. 2a). JC011                   thigh muscle SCID mice. JC011-treated hESCs failed form <br /> cytotoxic NCCIT embryonic carcinoma line IC50               teratomas SCID mice untreated controls readily <br /> value approximately 30 mM.                                              formed teratomas (Fig. 4). To better simulate efficacy a <br />    A time-course experiment assess quickly JC011              JC011-based enrichment strategy differentiation <br /> induce cell death 3 PSC lines used study indicated          protocol, heterogeneous populations BGO1V primary <br /> that maximum cell death ,96% attainable                  neonatal cardiomyocytes astrocytes mixed pre- <br /> following 36 hr incubation 20 mM JC011 (Figure S5 File           determined ratios (10:90, 20:80, 30:70, 60:40 50:50). The <br /> S1).                                                                       mixed cultures seeded, allowed adhere 14 hrs and <br />    To confirm specificity PSCs, obtained dose response          subsequently treated JC011 20 mM BGO1V- <br /> relationships JC011 4 normal human primary special-             cardiomyocyte cultures BGO1V-astrocyte cultures 12 hrs <br /> ized cells types ie. MRC-5 fibroblasts, primary human astrocytes           cultures analysed FACS SSEA-4 and <br /> (Lonza), primary human neurons (Neuromics) primary human               TRA-1-60 expression determine enrichment percentages. Up to <br /> neonatal cardiomyocytes (National Heart Centre, Singapore). Low            6-fold enrichment differentiated cardiomyocytes astrocytes <br /> cytotoxicity (,5% cell death) MRC-5, primary cardio-               obtained different mixed cell populations following <br /> myocytes primary astrocytes observed JC011                    JC011 treatment adversely affecting cell vitality (Fig. 4e). <br /> concentrations 100 mM (Figure S2 File S1). Primary             These results improvement 4.5-fold enrichment <br /> human neurons substantially sensitive             figures obtained single antibody sorting using classical <br /> JC011 treatment cell vitality affected concentrations           hESC SSEA-4 TRA-1-60 antibodies [14]. No increase <br /> 60 mM (Fig. 2b). We tested JC011 IC50 concentra-            cardiomyocyte cell death 5% observed following <br /> tion 20 mM human cell lines (HepG2, HeLa,              prolonged exposure (up 5 days) 20 mM JC011 (Fig. 4f). <br /> WI-38 normal human keratinocytes) resultant                To better understand toxicity JC011 vivo whole <br /> cell viability determined Resazurin analysis remained high        animal model, acute toxicity (LC50) JC011 determined in <br /> .97.5% (Figure S6 File S1). Additionally, PSC lines used         zebrafish. The results suggest JC011 toxic zebrafish <br /> this report .92% positive Tra-1-60 SSEA-4             embryos high concentrations (JC011 <br /> established FACS confirming specificity JC011           LC50 = 398.9 mM) (Figure S3 File S1). JC011 LC50 values for <br /> PSCs (Figure S7 File S1).                                               zebrafish embryos comparable magnitude reported <br />  <br />  <br /> PLOS ONE | www.plosone.org                                             2                            March 2014 | Volume 9 | Issue 3 | e85039 <br />                                   Pluripotent Stem Cell Cytotoxic Small Molecules <br />  <br />  <br />  <br />  <br /> PLOS ONE | www.plosone.org   3      March 2014 | Volume 9 | Issue 3 | e85039 <br />                                                                                                     Pluripotent Stem Cell Cytotoxic Small Molecules <br />  <br />  <br />  <br /> Figure 1. Morphology BGO1V-MEF cultures following treatment 20 mM JC011 12 hrs. &#226;&#8364;&#732;&#226;&#8364;&#732;Hollowing-out&#226;&#8364;&#8482;&#226;&#8364;&#8482; effect BGO1V-MEF <br /> cultures, feeders remain intact viable (A&#226;&#8364;&#8220;D). Trypan blue staining untreated control BGO1V single cells (E). Trypan blue staining JC011 <br /> treated BGO1V single cells showing increase Trypan blue uptake (F). Propidium Iodide DNA content analysis control untreated BGO1V cells <br /> (G). Propidium Iodide DNA content analysis JC011 treated BGO1V 6 hrs showing rapid increase sub-G1 fraction (H). R1 = sub-G1 <br /> fraction, R2 = G1 fraction, R3 = early/late S-phase fraction, R4 = G2/M fraction. <br /> doi:10.1371/journal.pone.0085039.g001 <br />  <br /> values FDA approved drugs Gentamycin                     statistically significant (p.0.05) (Figure S3 File S1). These <br /> Sulfate (440 mM) Verapamil Hydrochloride (170 mM) [21].                  data confirm JC011 developmentally toxic to <br />    In order assess developmental toxicity JC011,           developing zebrafish embryos gastrula stage onwards <br /> maximum non-lethal concentration (MNLC) determined                    support finding JC011 toxicity confined very <br /> exposing developing zebrafish JC011 early gastrula               early embryonic cells. <br /> stage 6 hours post fertilization(hpf)to 5 days post fertilization           Comparative gene expression profile analysis microarray <br /> (dpf). MNLC JC011 determined approximately                        performed elucidate mechanisms JC011- <br /> 425 mM. Zebrafish treated MNLC 6 hpf 5 dpf                   mediated PSC cytotoxicity. Total RNA JC011-treated <br /> and visually assessed using stereomicroscope. At 425 mM                    BGO1V cultures extracted 6 hr 12 hr time-points <br /> (MNLC), 21.1% (4/19) malformations observed. Zebrafish                  used gene expression analysis total RNA from <br /> treated JC011 exhibited accidental incidences trunk/tail/            untreated BGO1V cultures served controls. We rapid <br /> notochord, liver intestine malformation, figures          upregulation genes associated unfolded protein <br />  <br />  <br />  <br />  <br /> Figure 2. Dose response cytotoxicity data. Dose response curves 3 PSC cell lines (BGO1V, H9 iPS-Foreskin-1) following treatment with <br /> JC011 (A). Dose response curves 3 specialized somatic cell lines (MRC-5, human primary neurons human neonatal cardiomyocytes) treated <br /> with JC011 (B). Time course cytotoxicity analysis differentiating BGO1V cultures treated JC011 4-day intervals following bFGF withdrawal <br /> (C). Dose response curves 3 JC011 analogues (JC005, JC017 JC040) showing JC040 longer alkyl side-chain potent <br /> analogue (D). Cell viability values normalized untreated controls reported mean 6 S.D. independent experiments (n = 3). <br /> doi:10.1371/journal.pone.0085039.g002 <br />  <br />  <br /> PLOS ONE | www.plosone.org                                               4                            March 2014 | Volume 9 | Issue 3 | e85039 <br />                                                                                                Pluripotent Stem Cell Cytotoxic Small Molecules <br />  <br />  <br />  <br />  <br /> Figure 3. Table structure, molecular mass, ORAC DPPH antioxidant data 6 JC analogues (JC005, JC007, JC010, JC011, <br /> JC017 JC040). <br /> doi:10.1371/journal.pone.0085039.g003 <br />  <br /> response (UPR) known endoplasmic reticulum stress            CHAC1, ATF3 ATF4 key mediators PERK mediated <br /> response (ER stress) 6 hr 12 hr JC011-treated cultures.           UPR apoptosis; 4 genes highly <br /> More 10 ER stress related genes present         upregulated confirmed qRT-PCR (Fig. 5). <br /> the 50 upregulated list genes (Fig. 5).                              Moreover, microarray data indicated fluctuations in <br />    The ER stress response, known unfolded protein            oxidative stress calcium signalling JC011-treated BGO1V <br /> response (UPR), cellular stress mechanism activated              cells. GCLM GSR, 2 genes involved Glutathione <br /> response accumulation mis-folded proteins lumen          metabolism rapidly upregulated following <br /> of endoplasmic reticulum [22,23]. In conditions prolonged         JC011 treatment. Changes intracellular ROS levels following <br /> stress, UPR commits cell pathway apoptosis. Signalling       JC011 treatment examined fluorescent ROS <br /> intermediates downstream 3 main UPR receptor pathways             sensitive dye DCHF-DA. Unexpectedly, ROS levels DCHF- <br /> have identified having pro-apoptotic roles [22,23]. The 3        DA cells rapidly reduced following JC011 <br /> principal UPR receptors involved UPR apoptosis cascade            treatment BGO1V cells short incubation period 3 hrs. <br /> are Ire1, ATF6 PERK. Microarray analysis revealed            In contrast, ROS levels BGO1V cells reduced <br /> that downstream components genes PERK/ATF4/               following treatment non-cytotoxic JC005 JC007 <br /> DDIT3 pathway particular specifically upregulated             analogues JC011 JC005 share similar <br /> JC011-treated BGO1V cells. DDIT3 (also known CHOP),                   antioxidant profiles determined Oxygen Radical <br />  <br />  <br /> PLOS ONE | www.plosone.org                                           5                           March 2014 | Volume 9 | Issue 3 | e85039 <br />                                   Pluripotent Stem Cell Cytotoxic Small Molecules <br />  <br />  <br />  <br />  <br /> PLOS ONE | www.plosone.org   6      March 2014 | Volume 9 | Issue 3 | e85039 <br />                                                                                                        Pluripotent Stem Cell Cytotoxic Small Molecules <br />  <br />  <br />  <br /> Figure 4. JC011 treated PSCs fail form teratomas SCID mice effectively used enrich specialized cells. Teratoma <br /> sections SCID mice. Controls showing typical teratoma tissue organization representative 3 germ layers, A = Cartilage, B = Gut/Intestine, C, <br /> D = JC11 treated sample showing plain muscle tissue teratoma growth (A&#226;&#8364;&#8220;D). BGO1V primary neonatal cardiomyocytes mixed and <br /> seeded pre-determined ratios (10:90, 20:80, 30:70, 60:40 50:50). The mixed cultures treated JC011 20 mM 12 hrs followed by <br /> SSEA-4 TRA-1-60 FACS analysis determine enrichment ratios (E). Time course cell viability data JC011 (20 mM) treated primary neonatal <br /> cardiomyocytes indicate cardiomyocytes maintain high cell viability (.95%) 5-day incubation period JC011 (F). <br /> doi:10.1371/journal.pone.0085039.g004 <br />  <br /> Absorbance Capacity (ORAC) Di(phenyl)-(2,4,6-trinitrophe-                  specificity expression associated surface antigen. It is <br /> nyl)iminoazanium (DPPH) antioxidant assays (Fig. 6 &amp; Fig. 3).                  documented PSC cultures comprise mixed <br /> Instead, ROS levels increased following JC005 treatment               population cells slightly different phenotypes [3]. Conse- <br /> this increase associated observable cell death.               quently, undifferentiated cells sample not <br />    Next, pharmacological intervention well-studied ER                   express similar groups surface antigens; necessitate <br /> stress inducer dithiothreitol (DTT) performed determine              use multiple combinations antibodies antibody- <br /> JC011 mediated PSC cytotoxicity specific outcome JC011                based enrichment strategy. In addition, Fluorescence Activated <br /> treatment general non-specific outcome                Cell Sorting (FACS) Magnetic Activated Cell Sorting (MACS) <br /> replicated UPR/ER stress inducer. Treatment DTT,                   based enrichment protocols require single-cell suspensions. Ma- <br /> which causes disulphide bond disruption ER proteins, did                nipulation single cells appropriate tissue <br /> result observable increase BGO1V cell death                     engineering scenarios especially complex 2-D 3-D multi- <br /> compared untreated controls. PSC-specific cytotoxicity                   layer cell constructs final product transplantation. <br /> BGO1V cells replicated DTT treatments                           It difficult envisage use antibody a <br /> confirming JC molecule mediated PSC-specific cytotoxicity              preventive drug established clinical transplantation regime <br /> a property specific JC molecule series (Figure S8 File S1).          patients require administration drug period <br />    We performed siRNA knockdown 2 genes, DDIT3                     time following transplantation procedure prevent <br /> ATF4 confirm involvement PERK/ATF4/DDIT3 ER                          teratoma formation. Small molecules specifically <br /> stress pathway JC011 mediated PSC-specific cytotoxicity.                    cytotoxic PSCs non-toxic normal specialized cells could <br /> siRNA knockdown carried NCCIT cells maximum                     better solution scenarios. Small molecules cheaper <br /> transfection efficiency confirmation transcript knockdown               easier synthesize. They favourable pharmaco- <br /> was determined qRT-PCR. Briefly, NCCIT cells allowed                   kinetic profiles elaborate FACS MACS set-ups and <br /> to recover period 24 hrs following siRNA knockdown                protocols required. <br /> treated JC011. Cell viability analysis indicated ATF4                   While manuscript preparation, high throughput <br /> knockdown successfully attenuated JC011 cytotoxicity NCCIT                  screen study 50,000 small molecules reported the <br /> cells (P,0.05) confirming role PERK/ATF4/                       identification 15 pluripotent cell-specific inhibitors (PluriSIns) <br /> DDIT3 ER stress JC011 induced PSC cytotoxicity. DDIT3                       [26]. Interestingly, Ben-David et al determined most <br /> knockdown NCCIT cells showed similar attenuated                         selective PluriSIn induces ER stress apoptosis PSCs [26]; we <br /> cytotoxic response challenged JC011 data                   corroborate findings identifying ER stress pathway as <br /> were statistically significant (Fig. 7). This result         new target understanding signalling cascades which <br /> be components PERK/ATF4/DDIT3 ER stress                        govern apoptosis PSCs. <br /> pathway potentially substitute loss DDIT3 <br />                                                                                   However, contrast PluriSIns described study by <br /> activity. ROS levels determined DCHF-DA FACS used as <br />                                                                                Ben-David et al, compounds (JC011, JC010, JC017 and <br /> surrogate readout confirm knockdown ATF4 DDIT3. <br />                                                                                JC040) involved lipid metabolism molecules <br /> ATF4 knockdown resulted recovery ROS levels compa- <br />                                                                                structurally different share phenyl-hydrazine <br /> rable untreated controls DDIT3 knockdown resulted in <br />                                                                                moiety common feature 9 PluriSIns [26]. Instead, the <br /> no significant ROS recovery (Figure S9 File S1) <br />                                                                                4 JC compounds high ORAC DPPH values <br />                                                                                indicative strong anti-oxidant properties (Fig. 3). We also <br /> Discussion                                                                     establish JC molecule PSC cytotoxicity mediated mainly <br />     Considerable progress achieved establishing                    PERK/ATF4/DDIT3 signalling arm ER stress <br /> optimum conditions propagate differentiate PSCs                  pathway concomitant small rapid reduction of <br /> variety lineages functional specialized cells human cell             intracellular ROS levels. This observation unexpected <br /> replacement therapies. These advancements under-                   cell death result ER stress response more <br /> scored recent U. S Food Drug Administration approval                 commonly associated increase decrease in <br /> clinic trials use PSC-derived cells treat spinal cord injury         endogenous intracellular ROS levels [22,23]. <br /> macular degeneration [24,25]. Nonetheless, teratoma risk                      We present report group novel small organic <br /> associated contaminating PSCs differentiated cell popula-              molecules cytotoxic effective PSCs. These <br /> tions remains. This problem aggravated                 molecules easily efficiently synthesized having <br /> intrinsic propensity PSC derivatives undergo                       advantages existing antibody-based enrichment <br /> dedifferentiation situ [4,11]. Even ensuing data clinical           strategies removal PSCs differentiated <br /> trials supports efficacy safety PSC-based therapies,            progenies. These molecules useful vitro tool <br /> the teratoma risk continuously monitored                 help enrich certain differentiated PSC derivatives eradicating <br /> PSC-based therapies routinely applied clinical setting.               contaminating undifferentiated PSCs. Although toxicity towards <br />     Antibody-based solutions remove undifferentiated PSCs                primary cardiomyocytes (,5&#226;&#8364;&#8220;9%) observed following treat- <br /> vitro currently popular. The high specificity antibody               ment JC011 (20&#226;&#8364;&#8220;100 mM) toxicity astrocytes <br /> towards particular antigen drawbacks                     (,5%) observed 20 mM, acceptable JC011 <br /> antibody-based strategy theory limited                      concentrations ,20 mM sufficient reducing <br />  <br />  <br /> PLOS ONE | www.plosone.org                                                 7                             March 2014 | Volume 9 | Issue 3 | e85039 <br />                                                                                                  Pluripotent Stem Cell Cytotoxic Small Molecules <br />  <br />  <br />  <br />  <br /> Figure 5. Comparative microarray analysis reveals involvement PERK/ATF4/DDIT3 ER stress pathways. Clustering key <br /> differentially upregulated ER stress genes BGO1V following 6 hr 12 hr treatments 20 mM JC011 (A). Top 10 components PERK/ <br /> ATF4/DDIT3 ER stress pathway rapidly upregulated JC011 treated BGO1V cells (B). qRT-PCR confirmation upregulated <br /> UPR/ER stress pathway genes following JC011 treatment (C). <br /> doi:10.1371/journal.pone.0085039.g005 <br />  <br /> PSC contamination differentiated cell populations 6-           enrichment figures obtained single antibody sorting using <br /> fold (Fig. 4e). Additionally, prolonged exposure cardiomyocytes         classical hESC antibodies [14]. Primary neurons were <br /> to JC011 (20 mM) 5 days resulted increase          significantly affected JC011 20 mM; finding <br /> in cell death. These statistics improvement 4.5-fold <br />  <br />  <br /> PLOS ONE | www.plosone.org                                             8                           March 2014 | Volume 9 | Issue 3 | e85039 <br />                                   Pluripotent Stem Cell Cytotoxic Small Molecules <br />  <br />  <br />  <br />  <br /> PLOS ONE | www.plosone.org   9      March 2014 | Volume 9 | Issue 3 | e85039 <br />                                                                                                   Pluripotent Stem Cell Cytotoxic Small Molecules <br />  <br />  <br />  <br /> Figure 6. JC011 JC040 reduce ROS levels PSCs. Cytotoxic JC011 JC040 induce small rapid reduction intracellular ROS levels <br /> in BGO1V cells confirmed DCHF-DA FACS analysis 3 hrs treatment (A). JC007 (non-cytotoxic) does alter endogenous ROS levels while <br /> JC005 (non-cytotoxic) increases ROS levels corresponding cytotoxicity BGO1V (B). FACS histograms representative outcomes <br /> of 4 independent experiments. DCHF-DA stained JC011 treated BGO1V cells (C, D). DCHF-DA stained JC005 treated BGO1V cells (E, F). <br /> doi:10.1371/journal.pone.0085039.g006 <br />  <br />  <br /> could severely limit use JC compounds neuronal                FACS Propidium Iodide DNA Content Analysis <br /> differentiation strategies.                                                    Cells washed PBS followed fixation ice-cold <br />    Furthermore, corroborate findings Ben-David et al              70% ETOH 5 min. Fixed cells washed PBS twice <br /> [26] identifying ER stress pathway new target               resuspended 300 ml Propidium Iodide solution (69 mM <br /> understanding signalling cascades govern apoptosis             Propidium Iodide, 38 mM NaCitrate Sigma). 20 ml of <br /> PSCs. A deeper understanding PSC apoptosis machinery                 10 mg/ml RNase added remove interfering RNA. <br /> will provide effective means eliminate teratoma-forming cells         Following incubation 37uC 45 min, DNA content was <br /> from cell preparations clinically desirable phenotypes,                determined FACS analysis using Beckman Coulter Cell Lab <br /> triggering selective apoptosis PSCs potentially             Quanta SC. SSEA-4 TRA-1-60 antibodies used FACS <br /> solution eliminate unwanted teratoma-forming cells. Although             obtained Chemicon. All experiments performed in <br /> additional safety studies performed, findings                triplicate. <br /> indicate molecules the <br /> potential used safely vivo. Downstream,        Trypan Blue Cell Viability Analysis <br /> enrichment methods antibody-based sorting,                      Cell suspensions diluted 1:1 10 ml 0.4% w/v Trypan <br /> molecules function strategy safeguard         Blue Solution, incubated 10 min room temperature and <br /> against teratoma formation PSC-based cell replacement                    observed 206 phase optics hemocytometer cell <br /> regimes.                                                                    counting. <br />  <br /> Materials Methods                                                       ResazurinTM Cell Viability Analysis <br />                                                                                Cells seeded 96 multi-well dish format density <br /> Ethics Statement                                                            10,000 cells well. Cells washed PBS before <br />    This study carried strict accordance                 ResazurinTM (Sigma) solution (40 mg/ml final concentration) was <br /> recommendations Responsible Care Use Laboratory               added well. Following incubation period 2 hrs at <br /> Animals guide National University Singapore                   37uC fluorescence readouts obtained TecanTM plate <br /> Nanyang Polytechnic. All animal work conducted according                reader (Emission wavelength: 590 nm, Excitation wavelength: <br /> to relevant Singapore international NACLAR guidelines                535 nm, Gain = 25). All experiments performed quadru- <br /> the ASTAR Biological Resource Centre, Singapore. The animal                 plicate. <br /> experimentation protocol approved Institutional <br /> Animal Care Use Committee National University                 Total RNA Isolation First-Strand cDNA Synthesis <br /> Singapore (IACUC Permit No 090446). All surgery per-                       Total RNA extracted using TRIZOL (Life Technologies) <br /> formed sodium pentobarbital/ketamine mix anesthesia               reverse transcribed using SuperScript IITM first-strand <br /> all efforts minimize suffering. Only commercially              synthesis (Life Technologies). Total RNA quantified <br /> available pluripotent stem cell lines used research.           using ND-1000 spectrophotometer (NanoDrop Technologies, <br /> Approval pluripotent stem cell research obtained           Rockland, DE, USA) contaminating genomic DNA removed <br /> National University Singapore Institutional Review Board                 DNA-freeTM reagent (Life Technologies) reverse <br /> (NUS-IRB Review Permit No 09-301).                                          transcription. <br />  <br /> Cell Culture Protocols                                                      qRT-PCR <br />    All PSC lines cultured Dulbecco&#226;&#8364;&#8482;s modified Eagle&#226;&#8364;&#8482;s                  Real-time quantitative reverse transcriptase polymerase chain <br /> medium/Ham&#226;&#8364;&#8482;s F-12 medium containing GlutaMax supplement-                    reaction (qRT-PCR) analysis conducted using ABI <br /> ed 20% serum replacement, 1 mM sodium pyruvate,                        PRISM 7500 Fast Sequence Detection System using Predesigned <br /> 0.1 mM nonessential amino acids, (all Life Technologies),              Assays Demand TaqManTM probes primer pairs obtained <br /> 0.1 mM b-mercaptoethanol (Sigma), 8 ng/ml basic fibroblast              Life Technologies. After initial incubation step for <br /> growth factor (Chemicon). PSCs grown primary mouse                  2 minutes 50uC denaturation 10 minutes 95uC, <br /> embryonic fibroblasts (MEFs) obtained E12.5 d.p.c. 129sv               qRT-PCR carried using 40 cycles PCR (95uC for <br /> mice. Colonies serially passaged &#226;&#8364;&#732;&#226;&#8364;&#732;bulk culture&#226;&#8364;&#8482;&#226;&#8364;&#8482; format            15 seconds, 60uC 60 seconds). Equal amounts input first <br /> using Collagenase IV (Life Technologies) moved feeder-free           strand cDNA used qRT-PCR reactions, reactions <br /> culture mTeSRTM medium (Stem Cell Technologies)                     performed quadruplicate, GAPDH RNA levels served <br /> required. PSC lines passages 30 35 used            internal controls. Changes gene expression levels were <br /> study. HepG2, HeLa, WI-38, Human Keratinocytes, MRC-5                   calculated using 2ddCT method. Student&#226;&#8364;&#8482;s T-test statistic was <br /> NCCIT cells cultured recommended American Type                   used analyze qRT-PCR data. <br /> Culture Collection (ATCC). Primary hN2TM Human Neurons <br /> (Neuromics) grown hN2TM human neuron culture media                  Microarray <br /> (Neuromics). Primary human neonatal cardiomyocytes (Celpro-                    hESCS used microarray experiment grown feeder- <br /> gen) grown D10 media. Primary human astrocytes (Lonza)                 free .95% positive Tra-1-60 marker. Cell <br /> were cultured specialized human astrocyte media (Lonza).                 viability analysis Resazurin prior treatment JC011 <br />                                                                             showed cells .98.5% viable. RNA extracted using <br />  <br />  <br /> PLOS ONE | www.plosone.org                                             10                           March 2014 | Volume 9 | Issue 3 | e85039 <br />                                                                                                    Pluripotent Stem Cell Cytotoxic Small Molecules <br />  <br />  <br />  <br />  <br /> Figure 7. siRNA knockdown key ER stress genes ATF-4 DDIT3 leads reduced sensitivity JC011 NCCIT cells. <br /> ATF-4 DDIT3 silenced siRNA knockdown. Sensitivity JC011 attenuated DDIT3 knockdown ATF-4 knockdown <br /> (P,0.05) NCCIT cells confirming involvement PERK/ATF4/DDIT3 ER stress pathway JC011 mediated cytotoxicity (A&#226;&#8364;&#8220;E). qRT-PCR <br /> confirmation ATF-4 DDIT3 transcript knockdown (F). Cell viability figures normalized untreated controls reported mean 6 S.D. <br /> of independent experiments (n = 3). Statistical analysis performed Student&#226;&#8364;&#8482;s T-test. <br /> doi:10.1371/journal.pone.0085039.g007 <br />  <br /> standard TrizolTM protocol subjected spectrophotometric              ratios 1.78&#226;&#8364;&#8220;2.02 concentrations ranging from <br /> measurement (BioSPEC-Mini, Shimadzu) quality determined                 ,600 ng/mL ,980 ng/mL. Results Agilent Bioanaly- <br /> using Agilent Bioanalyzer. All samples OD260/OD280                  zer analysis showed samples RIN (RNA <br />  <br />  <br />  <br /> PLOS ONE | www.plosone.org                                             11                            March 2014 | Volume 9 | Issue 3 | e85039 <br />                                                                                                   Pluripotent Stem Cell Cytotoxic Small Molecules <br />  <br />  <br /> integrity Number) 7.5 9.5. The AgilentTM two-colour                   % abnormal zebrafish = (number abnormal zebrafish/ <br /> microarrays used comparative microarray analysis.                  20)6100%. The number zebrafish exhibiting MNLC was <br /> cRNA prepared according manufacturer&#226;&#8364;&#8482;s recom-                    counted compared vehicle control. Fisher&#226;&#8364;&#8482;s exact test was <br /> mended protocol (AgilentTM Two-Color Microarray-Based Gene                  used analyze data; compound considered teratogenic <br /> Expression Analysis, Quick Amp Labeling v5.7). Normalization                significant difference (p,0.05) observed compound <br /> and data analysis using GeneSpring GX version 10.0                 treated zebrafish. Detailed protocols provided supplemen- <br /> and Microsoft Excel. All experiments performed triplicate           tary material. All zebrafish developmental toxicity assays were <br /> (N = 3). A gene considered differentially expressed fold-            performed contract service provider, GenScript Pte Ltd. <br /> difference relative controls $3. <br />                                                                             siRNA Transfection <br /> DCHF-DA ROS Detection, ER Stress Induction N-                              Cells seeded 24-well plates 48 hours siRNA <br /> acetyl cysteine treatment                                                   transfection order 60&#226;&#8364;&#8220;70% confluency day of <br />    DCHF-DA solution used final working concentration               transfection. Cells transfected siRNA (Dharmacon) <br /> of 10 mM. Adherent cells PBS solution incubated 5 min               targeting (ATF4 DDIT3) control siRNA final <br /> room temp DCHF-DA cells visualized                    concentration 100 nM using DharmaFECT 2 reagent (Dhar- <br /> under fluorescence microscope FITC filters. Bright green               macon). ON-TARGET plus siRNA pool (Dharmacon) used <br /> fluorescing cells indicative cells high ROS content.           knockdown experiments contains pool four <br /> To induce non-specific ER stress, DTT (Sigma) added                individual siRNA sequences target gene. RNA knockdown <br /> final concentration 3 mM. All experiments performed              confirmed assessing mRNA levels qRT-PCR. <br /> triplicate. All DCHF-DA experiments performed 3 hr <br /> incubation period JC011. Cells treated ROS                   Preparative HPLC Protocol <br /> scavenger N-acetyl cysteine (Sigma) final concentration                Preparative HPLC performed Shimadzu LC-8A <br /> 100 mM.                                                                     HPLC equipped CBM-20A PDA detector, Gilson <br />                                                                             215 liquid handler fraction collector using X-Bridge Prep <br /> Teratoma Formation SCID mice                                             C18 (30 mm I.D.650 mm, 5 m) column. An isocratic elution with <br />    Approximately 1 million stem cells injected intramuscu-             20% CH3CN, 80% (0.1% formic acid/H2O) flow rate of <br /> larly right hind leg 10-week-old male SCID-beige              20.0 mL/min 5 min used. This followed gradient <br /> mouse. 5 mice used experimental arm including                 elution starting 20% CH3CN, 80% (0.1% formic acid/H2O), <br /> controls. Mice monitored 2&#226;&#8364;&#8220;3 times/week period 15             ending 100% CH3CN flow <br /> weeks size teratomas recorded weekly. Histological <br /> evaluation paraffin embedded teratoma sections performed             Liquid Chromatography-Mass Spectrometry (LC-MS) <br /> with H&amp;E staining trained pathologist. All animal experi-                 LC-MS data JC005, JC007, JC010, JC011, JC017 and <br /> ments carried strict accordance recommen-              JC040 collected Shimadzu LCMS-IT-TOF instrument <br /> dations Responsible Care Use Laboratory Animals               equipped SPD-M20A PDA detector, LCMS-IT-TOF MS <br /> guide National University Singapore Nanyang                   detector LC-20AD binary gradient pump using Shimpack <br /> Polytechnic.                                                                VP-ODS (2.0 mm I.D.6150 mm) column (File S1). An isocratic <br />                                                                             elution 20% H2O 80% CH3CN flow rate of <br /> Zebrafish Acute Toxicity Determination                                      0.2 mL/min 3 min used. <br />    Dechorionated wild-type AB strain zebrafish distributed <br /> into 12-well plates 3 ml fresh fish water. To determine LC50,            Nuclear Magnetic Resonance (NMR) Spectroscopy <br /> zebrafish treated 2 dpf 5 dpf. Ten concentrations:               1 <br />                                                                                 H 13C NMR spectra JC010, JC011 JC040 were <br /> 0.01, 0.05, 0.1, 0.5, 1, 5, 10, 50, 100 500 mM assessed         recorded Bruker AVANCE-400 NMR spectrometer (File S1). <br /> estimate LC50. Dead zebrafish counted removed daily.               The compounds dissolved CD3OD. <br /> At end treatment, total number dead animals used to <br /> generate lethality curve plotting % lethality vs concentration. <br />                                                                             Synthetic Procedure Analogues JC005, JC011, JC040, <br /> Based lethality curves, LC50s estimated logistic <br /> regression JMP8 software. Experiments performed 3             JC048-050 <br /> times obtain mean SD LC50. Detailed protocols                    To solution hydrochloride hydrobromide salt an <br /> provided File S1. All zebrafish acute toxicity assays           amine (1 mmol) anhydrous N,N-dimethylformamide (DMF) <br /> performed contract service provider, GenScript Pte Ltd.                (2 mL) added N,N-diisopropylethylamine (DIPEA) (2 mmol) <br />                                                                             liberate amine. After stirring room temperature for <br /> Zebrafish Teratogenicity Determination                                      10 min, nonanoyl chloride (1 mmol) added. The solution was <br />                                                                             stirred room temperature 6 24 h. After reaction, water <br />    Chorionated wild-type AB strain zebrafish distributed into <br />                                                                             (40 mL) added solution. The reaction mixture was <br /> 6-well plates 3 ml fresh fish water. To determine developmental <br /> toxicity, zebrafish treated MNLC 6 hpf (Gastrula               transferred separating funnel extracted dichloro- <br /> stage) 5 dpf. Zebrafish treated 0.1 mM 9-cis retinoic acid          methane, CH2Cl2 (366 mL). The organic extracts concen- <br /> served positive control 0.1% DMSO vehicle control.                trated reduced pressure crude product. The crude <br /> Untreated zebrafish used demonstrate vehicle (0.1%                  product purified silica gel column chromatography <br /> DMSO) did adverse effect zebrafish. At end               (using hexane/ethyl acetate, 2:1 v/v, eluent) preparative <br /> treatment, zebrafish visually assessed using dissecting              HPLC (using protocol set above) final product <br /> microscope malformations. A zebrafish exhibiting defects             (Figure S10 File S1). <br /> any end point considered abnormal % abnormal animal <br /> for compound determined using following formula: <br />  <br />  <br /> PLOS ONE | www.plosone.org                                             12                           March 2014 | Volume 9 | Issue 3 | e85039 <br />                                                                                                                          Pluripotent Stem Cell Cytotoxic Small Molecules <br />  <br />  <br />  <br /> Synthetic Procedure Analogues JC007, JC010                                           determined Resazurin analysis remained high .97.5% for <br /> JC017                                                                                        cell lines. Cell death values normalized untreated controls <br />    To solution hydrochloride hydrobromide salt                             reported mean 6 S.D. independent experiments <br /> amine (1&#226;&#8364;&#8220;2 mmol) anhydrous dichloromethane, tetrahydrofu-                                 (n = 3). Figure S7 File S1: Tra-1-60 SSEA-4 immunomar- <br /> ran N,N-dimethylformamide (DMF) (2&#226;&#8364;&#8220;4 mL) added N,N-                                   ker FACS analysis BGO1V, H9 iPSC-foreskin-1. All PSC <br /> diisopropylethylamine (DIPEA) (1&#226;&#8364;&#8220;2 mmol) liberate amine.                              lines .95% positive Tra-1-60 SSEA-4 stem cell- <br /> After stirring room temperature 10 min, isocyanate (1&#226;&#8364;&#8220;                                specific antigens (n = 3). Figure S8 File S1: Non-specific ER <br /> 2 mmol) added. The solution stirred room temperature                              stress inducer DTT does induce cell death BGO1V. PSC- <br /> for 6 24 h. After reaction, water (20 mL) added                            cytotoxicity BGO1V cells replicated DTT <br /> solution. The reaction mixture transferred separating                               treatment confirming JC011 mediated PSC-cytotoxicity a <br /> funnel extracted dichloromethane, CH2Cl2 (3610 mL).                                 property specific JC molecule series. Cell death values are <br /> The organic extracts concentrated reduced pressure                             normalized untreated controls reported mean 6 S.D. of <br /> give crude product, purified silica gel column                                independent experiments (n = 3), * = P,0.05. Figure S9 in <br /> chromatography (using hexane/ethyl acetate, 2:1 v/v, eluent)                           File S1: Surrogate ROS levels NCCIT following ATF4 and <br /> preparative HPLC (using protocol set above)                              DDIT3 siRNA knockdown. ATF4 knockdown resulted a <br /> final product (Figure S11 File S1)..                                                      recovery ROS levels JC011 (20 mM) treated NCCIT cells <br />                                                                                              comparable untreated controls. DDIT3 knockdown resulted in <br /> Supporting Information                                                                       significant recovery ROS levels (n = 3). Figure S10 File S1: <br />                                                                                              Synthetic Procedure Analogues JC005, JC011, JC040, JC048- <br /> File S1 Figures S1&#226;&#8364;&#8220;S11. Figure S1 File S1: Table LC-MS <br />                                                                                              050. Figure S11 File S1: Synthetic Procedure Analogues <br /> data JC analogues. Figure S2 File S1: NMR spectra JC                              JC007, JC010 JC017. <br /> analogues. Figure S3 File S1: Zebrafish acute toxicity and <br />                                                                                              (DOCX) <br /> developmental study data. Figure S4 File S1: Normal human <br /> astrocytes (Lonza) treated JC005, JC010, JC011 and <br /> JC017 20 mM final concentration 12 hrs following                            Acknowledgments <br /> Resazurin assay used determine cell viability. Cell death                             The authors like express gratitude Dr Moe Kyaw-Thu of <br /> values normalized untreated controls reported mean                             National Heart Centre, Singapore, gift neonatal <br /> 6 S.D. independent experiments (n = 3). Figure S5 File                           cardiomyocytes (Celprogen) used study. <br /> S1: Time-course cell viability study determine kinetics JC011 <br /> mediated cell death 3 PSC lines. Maximum cell death                                    Author Contributions <br /> approximately 96% attained BGO1V H9 following <br />                                                                                              Conceived designed experiments: MR CWP JMKL. Performed <br /> a 36 hr incubation 20 mM JC011. Cell death values                                   experiments: MR GTWG CWP CMFT EKS XMG. Analyzed the <br /> normalized untreated controls reported mean 6 S.D.                              data: MR CWP. Contributed reagents/materials/analysis tools: MR <br /> three independent experiments (n = 3). Figure S6 File S1: Cell                            GTWG CWP CMFT EKS XMG. Wrote paper: MR CWP WKC <br /> viability analysis JC011 (20 mM, 12 hrs) treated HepG2, HeLa,                            JMKL. <br /> WI-38 normal human keratinocytes. Resultant cell viability as <br />  <br /> References <br />  1. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007)                     13. Idelson M, Alper R, Obolensky A, Ben-Shushan E, Hemo I, et al. (2009) <br />     Induction pluripotent stem cells adult human fibroblasts defined                  Directed differentiation human embryonic stem cells functional retinal <br />     factors. Cell 131 : 861&#226;&#8364;&#8220;872.                                                                 pigment epithelium cells. Cell Stem Cell 5: 396&#226;&#8364;&#8220;408. <br />  2. Richards M, Fong CY, Chan WK, Wong PC, Bongso A (2002) Human feeders                     14. Fong CY, Peh GS, Gauthaman K, Bongso A (2009) Separation SSEA-4 and <br />     support prolonged undifferentiated growth human inner cell masses                     TRA-1-60 Labelled Undifferentiated Human Embryonic Stem Cells A <br />     embryonic stem cells. Nature Biotechnol 20: 933&#226;&#8364;&#8220;936.              <br /> </body></html>